Griffith University in Australia has partnered with vaccines manufacturing company Indian Immunologicals (IIL) to develop a Covid-19 vaccine.
The partners intend to create a live attenuated vaccine. They will use codon de-optimisation technology to alter the virus’ genome to reduce its replication efficiency in human cells, making it harmless.
According to the researchers, the vaccine will mimic the infection but cannot cause disease, while also capable of stimulating all arms of the immune response.
The vaccine could offer long-lasting immunity against SARS-CoV-2, the novel coronavirus that causes Covid-19, with a single immunisation.